Invesco S&P 500 Momentum ETF vs Veeva Systems — how do they compare? Invesco S&P 500 Momentum ETF trades at $150.46, while Veeva Systems trades at $260.88 (market cap $42.88B). Which is the better fit depends on your goals.
| SPMO | VEEV | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $161.66 | $306.22 |
52-Week Low | $107.84 | $151.43 |
Market Cap | — | $42.88B |
Enterprise Value | — | $35.79B |
Signals from Pluang's Aura AI — not financial advice
SPMO trades at $150.47, up 0.5% with a bullish technical outlook supported by strong moving average signals. The ETF has delivered exceptional performance, averaging 37% annual returns over three years according to The Motley Fool (2026-09-06). Recent momentum factor strength and concentrated tech exposure drive its market-beating track record, though this introduces higher volatility during sector rotations.
The outlook remains positive with structural momentum advantages and lower drawdowns than the S&P 500. Key risks include concentrated technology sector exposure and sensitivity to market rotations. Analyst sentiment leans bullish with multiple buy recommendations citing the ETF's rules-based momentum strategy and cost efficiency at 0.13% expense ratio.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →